GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $9,019,000 | +32.3% | 617,722 | +28.6% | 2.31% | +28.0% |
Q3 2020 | $6,819,000 | -42.1% | 480,199 | -40.0% | 1.81% | -45.5% |
Q2 2020 | $11,768,000 | +1328.2% | 800,000 | +300.0% | 3.32% | +767.8% |
Q1 2020 | $824,000 | -59.2% | 200,000 | -52.4% | 0.38% | -34.5% |
Q4 2019 | $2,020,000 | – | 420,000 | – | 0.58% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |